Research shows a longer breastfeeding duration is associated with reduced maternal rates of type 2 diabetes and less postpartum weight retention
In this article, we'll look at what the research says about stopping GLP-1 medications, why the body responds the way it does, and - most importantly - the practical steps you can take to support your progress and set yourself up well for the transition
The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptideregardless of etiology and phenotype
This includes cases where the clinician declines to prescribe
Some studies indicate that approximately 20-30% of weight loss from GLP-1 therapy may come from lean masssimilar to dietary interventions
In synovial macrophages, liraglutide treatment shifted cells from a pro-inflammatory M1 phenotype toward an anti-inflammatory M2 state, a transition that correlated with an overall reduction in inflammatory activity